锌指BED结构域包含蛋白3通过与多聚嘧啶区结合蛋白1相互作用促进肝脂肪变性
本研究探讨锌指BED结构域包含蛋白3(ZBED3)在代谢功能障碍相关脂肪性肝病(MASLD)中的作用。在MASLD患者肝脏及细胞和动物模型中,ZBED3表达上调;过表达ZBED3促进肝细胞甘油三酯积累和肝脂肪变性,而肝细胞特异性敲除Zbed3可抵抗高脂饮食诱导的肝脂肪变性。机制上,ZBED3与多聚嘧啶区结合蛋白1(PTBP1)直接相互作用,影响其与SREBP1c mRNA前体的结合,从而调控SREBP1c mRNA稳定性和可变剪接。
要点
- ZBED3在MASLD患者肝脏及MASLD动物模型中显著上调。
- 肝细胞过表达ZBED3促进肝脂肪变性,肝细胞特异性敲除Zbed3可抵抗高脂饮食诱导的肝脂肪变性。
- ZBED3与PTBP1直接相互作用,调控SREBP1c mRNA稳定性和可变剪接。
核心结论
- 本研究表明ZBED3促进肝脂肪变性,是MASLD进展的关键调控因子。
研究设计与样本
- 研究评估了MASLD个体以及MASLD细胞模型和动物模型中ZBED3的表达水平。
- 体外分析使用非酯化脂肪酸(NEFA)诱导的MASLD细胞模型,体内分析使用高脂饮食(HFD)诱导的MASLD动物模型。
- 通过慢病毒感染或尾静脉注射腺相关病毒增加ZBED3表达,并采用RNA-seq和生物信息学分析探讨ZBED3调控脂质积累的通路。
- 利用免疫共沉淀和液相色谱-串联质谱(LC-MS/MS)研究ZBED3调控固醇调节元件结合蛋白1c(SREBP1c)的分子机制。
主要发现
- ZBED3在MASLD个体肝脏和MASLD动物模型中显著上调。
- ZBED3过表达促进NEFA诱导的肝细胞体外甘油三酯积累。
- 肝细胞特异性过表达Zbed3促进肝脂肪变性;反之,肝细胞特异性敲除Zbed3导致对HFD诱导的肝脂肪变性产生抵抗。
- 机制上,ZBED3与PTBP1直接相互作用,影响其与SREBP1c mRNA前体的结合,从而调控SREBP1c mRNA稳定性和可变剪接。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus, insulin resistance and the metabolic syndrome is well established. While zinc finger BED-type containing 3 (ZBED3) has been linked to type 2 diabetes mellitus and the metabolic syndrome, its role in MASLD remains unclear. In this study, we aimed to investigate the function of ZBED3 in the context of MASLD. METHODS: Expression levels of ZBED3 were assessed in individuals with MASLD, as well as in cellular and animal models of MASLD. In vitro and in vivo analyses were conducted using a cellular model of MASLD induced by NEFA and an animal model of MASLD induced by a high-fat diet (HFD), respectively, to investigate the role of ZBED3 in MASLD. ZBED3 expression was increased by lentiviral infection or tail-vein injection of adeno-associated virus. RNA-seq and bioinformatics analysis were employed to examine the pathways through which ZBED3 modulates lipid accumulation. Findings from these next-generation transcriptome sequencing studies indicated that ZBED3 controls SREBP1c (also known as SREBF1; a gene involved in fatty acid de novo synthesis); thus, co-immunoprecipitation and LC-MS/MS were utilised to investigate the molecular mechanisms by which ZBED3 regulates the sterol regulatory element binding protein 1c (SREBP1c). RESULTS: In this study, we found that ZBED3 was significantly upregulated in the liver of individuals with MASLD and in MASLD animal models. ZBED3 overexpression promoted NEFA-induced triglyceride accumulation in hepatocytes in vitro. Furthermore, the hepatocyte-specific overexpression of Zbed3 promoted hepatic steatosis. Conversely, the hepatocyte-specific knockout of Zbed3 resulted in resistance of HFD-induced hepatic steatosis. Mechanistically, ZBED3 interacts directly with polypyrimidine tract-binding protein 1 (PTBP1) and affects its binding to the SREBP1c mRNA precursor to regulate SREBP1c mRNA stability and alternative splicing. CONCLUSIONS/INTERPRETATION: This study indicates that ZBED3 promotes hepatic steatosis and serves as a critical regulator of the progression of MASLD. DATA AVAILABILITY: RNA-seq data have been deposited in the NCBI Gene Expression Omnibus ( www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE231875 ). MS proteomics data have been deposited to the ProteomeXchange Consortium via the iProX partner repository ( https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD041743 ).
引用
- Wu Y, Yang M, Wu SB, et al. Zinc finger BED-type containing 3 promotes hepatic steatosis by interacting with polypyrimidine tract-binding protein 1. Diabetologia. 2024. PMID: 39037604. doi:10.1007/s00125-024-06224-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。